INDEPENDENT INTELLIGENCE
LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Legend Biotech Corporation

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERLEGN
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / LEGN COVERAGE

What’s moving Legend Biotech Corporation now

Current reporting with the operating signal separated from the noise.

01
Legend Biotech Corporation Announces Pricing of Public Offering

Legend Biotech Corporation Announces Pricing of Public Offering

The story matters when it changes Legend Biotech Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Legend Biotech Corporation (LEGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Legend Biotech Corporation (LEGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

The story matters when it changes Legend Biotech Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Depositary Receipt (LEGN) with Outperform Recommendation

Oppenheimer Initiates Coverage of Legend Biotech Corporation

The story matters when it changes Legend Biotech Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts

Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts

Investors are testing whether Legend Biotech Corporation’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
Legend Biotech Corporation (LEGN): The Biotech Stock with Biggest Upside Potential

Legend Biotech Corporation (LEGN): The Biotech Stock with Biggest Upside Potential

Investors are testing whether Legend Biotech Corporation’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest LEGN filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

6-KOfficial SEC filingFiled 2026-07-27 · Period 2026-07-27SEC ↗6-KOfficial SEC filingFiled 2026-07-15 · Period 2026-07-15SEC ↗3Official SEC filingFiled 2026-08-03 · Period 2026-07-24SEC ↗4Official SEC filingFiled 2026-07-02 · Period 2026-06-30SEC ↗4Official SEC filingFiled 2026-07-02 · Period 2026-06-30SEC ↗144Official SEC filingFiled 2026-06-30SEC ↗4Official SEC filingFiled 2026-06-29 · Period 2026-06-25SEC ↗144Official SEC filingFiled 2026-06-26SEC ↗
EARNINGS / QUARTERLY TRACKER

Legend Biotech Corporation, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.